NYU Langone Health
New York, 10016, United States
NCT Number: NCT05870527
The research team will evaluate pupillary dilation from vagal nerve stimulation of Arnold's Nerve, a branch of the vagus nerve, during routine cochlear implantation surgery.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
New York, 10016, United States
The objective of this study is to determine if electrical stimulation of Arnold's Nerve, a branch of the vagus nerve, can result in vagal nerve response through the measurement of pupillary dilation
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients undergoing cochlear implantation:
Patients undergoing vagal nerve stimulator implantation:
Exclusion criteria
Patients undergoing cochlear implantation:
Patients undergoing vagal nerve stimulator implantation:
Electrical stimulation will be used to stimulate the Arnold's nerve and measure pupil dilation. The electrical stimulator is part of the standard facial nerve monitoring unit that we utilize in cochlear implantation and will be setup prior to surgery in standard fashion. The device allows for constant current stimulation, with stimulus range between 0-30 mA.
Time frame: Day 1 (During procedure - typically 1 hour in duration)
Pupillary dilation (mm) measured via non-invasive pupillary measurement camera.
NYU Langone Health
Other
Single-Center Study of Pupillary Dilation During Post-Auricular Vagal Nerve Stimulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04673565
Deafness, Ear Diseases
Vancouver, British Columbia, Canada
View Trial DetailsNCT05110183
Ear Diseases, Hearing Disorders
Coral Gables, Florida, United States
View Trial DetailsNCT05176561
Deafness, Ear Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06803394
Age-related Hearing Impairment, Behavior
Baltimore, Maryland, United States
View Trial Details